Lizhu Chen

6PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 05, 2026
Efficacy and Safety of DNV3 (a Lymphocyte-activation Gene 3-blocking Antibody) Combined With Toripalimab and Chemotherapy in Advanced Melanoma: An Open-label, Single-arm Clinical Trial.

Jing Lin, Lizhu Chen, Ling Chen

|Nov 18, 2025
Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis.

Zhongqiao Lin, Li Zhu, Yuyang Huang

|Mar 25, 2025
DNA-PKcs Dysfunction Enhances the Antitumor Activity of Radioimmunotherapy by Activating the cGAS-STING Pathway in HNSCC.

Lizhu Chen, Jing Lin, Yaoming Wen

|Jan 27, 2023
An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status.

Lizhu Chen, Yaoming Wen, Jiani Xiong

|Dec 13, 2022
FAM3D as a Prognostic Indicator of Head and Neck Squamous Cell Carcinoma Is Associated with Immune Infiltration.

Lizhu Chen, Jie Lin, Bin Lan

|Jul 11, 2022
Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.

Jie Lin, Lizhu Chen, Dingjie Wu

Pageof 1

Frequent Collaborators

2 joint publications

Jie Lin

2 joint publications

Jiani Xiong

2 joint publications

Yaoming Wen

2 joint publications

Yu Chen